A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer's Disease

A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer's Disease
复制标题

DOI:
10.3389/fnmol.2019.00310
复制
发表时间:
2019-12-12
影响因子:
4.8
通讯作者:
Reis, Robert J. Shmookler
Reis, Robert J. Shmookler
中科院分区:
医学2区
文献类型:
--
作者:
Kakraba, Samuel;Ayyadevara, Srinivas;Reis, Robert J. Shmookler

文献摘要

被引文献

相似文献

年龄进行性神经退行性病变,包括阿尔茨海默病(AD),通过细胞内或细胞外聚集的疾病特定成分来区分和诊断。越来越多的证据表明,神经炎症促进了蛋白质聚集,并参与了神经系统疾病的病因学。我们合成并测试了天然产生的微管蛋白结合化合物的类似物,comretasteatin A-4。其中一种类似物PNR502显著减少了BRI-A beta(1-42)AD小鼠模型中阿尔茨海默病相关淀粉样聚集体的数量,同时削弱了促炎细胞因子IL-1β在神经细胞培养模型中提高淀粉样斑块及其蛋白前体水平的能力。在肌肉或神经元表达人Aβ(1-42)的转基因秀丽线虫品系中,PNR502分别挽救了Aβ诱导的运动性(3.8倍,P<0.0001)和趋化性(1.8倍,P<0.05)中断。此外,在神经元表达Aβ(1-42)的线虫中,一天暴露于PNR502可逆转54%的趋化缺陷(P<0.01),实际上超过了长期暴露的保护。此外,连续使用PNR502可使线虫寿命延长23%(P
Age-progressive neurodegenerative pathologies, including Alzheimer's disease (AD), are distinguished and diagnosed by disease-specific components of intra- or extra-cellular aggregates. Increasing evidence suggests that neuroinflammation promotes protein aggregation, and is involved in the etiology of neurological diseases. We synthesized and tested analogs of the naturally occurring tubulin-binding compound, combretastatin A-4. One such analog, PNR502, markedly reduced the quantity of Alzheimer-associated amyloid aggregates in the BRI-A beta(1-42) mouse model of AD, while blunting the ability of the pro-inflammatory cytokine IL-1 beta to raise levels of amyloid plaque and its protein precursors in a neuronal cell-culture model. In transgenic Caenorhabditis elegans (C. elegans) strains that express human A beta(1-42) in muscle or neurons, PNR502 rescued A beta-induced disruption of motility (3.8-fold, P < 0.0001) or chemotaxis (1.8-fold, P < 0.05), respectively. Moreover, in C. elegans with neuronal expression of A beta(1-42), a single day of PNR502 exposure reverses the chemotaxis deficit by 54% (P < 0.01), actually exceeding the protection from longer exposure. Moreover, continuous PNR502 treatment extends nematode lifespan 23% (P